Connecticut health officials have confirmed the first flu death of the 2025-26 season, with an elderly adult from Hartford County succumbing to the virus. The individual, aged between 80 and 89 years, died during the week of October 25, 2025, marking a somber start to the respiratory viral disease season.
In a statement addressing the situation, Manisha Juthani, Commissioner of the Connecticut Department of Public Health, emphasized the critical nature of the flu season. “This is a tragic reminder that the 2025-26 respiratory viral disease season is here. As we approach Thanksgiving and the holidays, more people gather together and spend more time indoors,” she stated. Juthani urged residents who have not yet received their seasonal vaccinations to take action to protect themselves and those most at risk.
Despite current flu levels remaining low throughout Connecticut, health care officials anticipate a rise in cases as the holiday season approaches. Currently, COVID-19 remains the most active virus in circulation, with reports of seven COVID-19-related deaths this season. In contrast, only one flu death has been confirmed, and there have been no reported deaths due to respiratory syncytial virus (RSV).
As the potential for increased flu activity looms, health officials are stressing the importance of vaccination for all residents, particularly those at greater risk. Vulnerable groups include infants, older adults, pregnant women, and individuals with weakened immune systems. Vaccination not only helps protect individuals but also contributes to community immunity, reducing the overall spread of illness and alleviating pressure on healthcare resources.
The Connecticut Department of Public Health has outlined its current vaccination and prevention recommendations. These include:
– Annual influenza vaccinations for everyone aged 6 months and older.
– Updated COVID-19 vaccinations for everyone aged 6 months and older.
– RSV vaccinations for adults aged 60 and older, as well as for pregnant individuals.
– Administration of the monoclonal antibody Nirsevimab for all infants younger than 8 months.
With the holidays approaching, health officials are hopeful that increased vaccination rates will help mitigate the anticipated rise in flu cases. They encourage all residents to take proactive steps for their health and the health of their communities as the season progresses.
